Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NICE on u/s-guided foam sclerotherapy:

This article was originally published in Clinica

Executive Summary

The UK National Institute for Health and Clinical Excellence (NICE) has deemed ultrasound-guided foam sclerotherapy to be effective in treating varicose veins in the short term. In an update of the interventional procedures (IP) guidance it issued on the technique in June 2006, NICE notes "transient side effects in a small proportion of patients", thereby requiring special arrangements for consent and audit/research. The guidance has been endorsed by NHS Quality Improvement Scotland, making it valid for the whole of the UK. However, IP appraisals do not assess clinical demand for the procedure - nor have they any legal weight - so provide no indication of their impact on the use of the technologies involved. The "special arrangements" attached to NICE's decisions on interventional procedures are the subject of an open consultation.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT048804

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel